Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World

Donegal Woman First to Receive Groundbreaking Walking Treatment

July 31, 2025 Victoria Sterling -Business Editor Business

Donegal Woman First in World to Receive Revolutionary Treatment⁢ for Venous Obstructions

Table of Contents

  • Donegal Woman First in World to Receive Revolutionary Treatment⁢ for Venous Obstructions
    • A Life-Altering Condition
    • The‌ Recana System: A new Era‍ of Treatment
    • A Patient’s Journey to Recovery
    • A Triumph for University Hospital Galway and Innovation
    • Collaborative ⁤Success Fueled​ by Hypercare Initiative

Galway,Ireland – In a⁤ groundbreaking medical advancement,a Donegal woman has become the first patient globally ‍to ​undergo a revolutionary new treatment for complex venous obstructions,offering renewed hope and significantly improved quality of‍ life.Kelly Coughlin received the pioneering treatment at University Hospital Galway, marking a meaningful​ milestone in interventional radiology and patient care.

A Life-Altering Condition

Venous⁤ obstructions, particularly in previously stented vessels, can ​lead to ⁤debilitating⁣ symptoms, severely impacting a ​patient’s mobility and daily‌ life. For ‍Kelly, the condition had made even simple tasks like walking a significant challenge.

Professor Gerry ​O’Sullivan, Consultant Interventional Radiologist at University Hospital Galway, who led ⁣the procedure, highlighted the severity of such ⁣conditions.”The impact‍ of‌ venous⁣ obstructions, especially in previously stented vessels, can be life-altering,” he stated. “we had ‌attempted to recanalise this patient’s ‍veins four times without success.”

The‌ Recana System: A new Era‍ of Treatment

The successful intervention was made possible by the Recana Thrombectomy Catheter System, a novel device designed to tackle complex venous blockages.Professor O’sullivan expressed his enthusiasm for the system’s efficacy. “The Recana system achieved this in a single session. That speaks volumes⁣ about its ‍potential,”⁤ he remarked.Professor O’sullivan further elaborated⁤ on the⁢ system’s advantages. “It ⁣offers a powerful, minimally invasive solution for patients who have exhausted conventional treatment options,” he added.

A Patient’s Journey to Recovery

Kelly Coughlin, the ‌first recipient of this life-changing ⁣treatment, shared her profound experience. “This procedure⁢ has been massively life-changing for⁤ me,” she ⁢saeid. “When I was ⁤symptomatic, even​ simple tasks like walking were a challenge.”

Her confidence in the medical team was a crucial factor in her decision ‍to undergo the procedure. “I’m incredibly grateful to Professor O’Sullivan and his team at University hospital Galway. I’ve been under his care‍ for many years, and that long-standing trust gave me the confidence and reassurance I needed to proceed wiht this ⁤treatment.”

A Triumph for University Hospital Galway and Innovation

The successful trial of the Recana system at University Hospital Galway has been lauded as a significant achievement for the institution and a testament to its commitment to ‌clinical excellence and innovation.

Chris Kane, hospital​ Manager, praised the groundbreaking ⁤work. “This is a significant ⁣achievement for University Hospital Galway and reflects our unwavering commitment to clinical‌ excellence and innovation. Being the first in the ⁢world to trial this​ ground-breaking device ⁤showcases both the expertise of our medical teams ⁢and the strength of our collaborative ⁤research partnerships.”

Collaborative ⁤Success Fueled​ by Hypercare Initiative

The introduction of this cutting-edge medical device in Ireland is ​a direct result of the collaborative efforts within the University of Galway’s Institute ‌for Clinical Trials and ‍its hypercare initiative.

Professor Fidelma Dunne, Director of the Institute ⁢for Clinical⁤ Trials at University of Galway, celebrated‌ the successful partnership. “It ‌is incredibly rewarding to see cutting-edge medical device innovation introduced in⁣ Ireland through the Hypercare initiative at University of Galway’s Institute for Clinical Trials,” she stated.Professor Dunne explained the strategic importance of Hypercare. “Hypercare was developed to streamline and accelerate the start-up of clinical trials by working closely with our regulatory, ethical, and healthcare delivery partners. This milestone is a clear reflection‌ of that mission in ​action.”

This global ⁣breakthrough ​signifies a‍ new⁢ dawn for patients suffering from complex venous obstructions, offering a less invasive⁣ and ⁤more effective path to recovery and improved ‍mobility.

**

Pictured above: Donegal woman⁢ Kelly Coughlin, the first‌ patient in the world to receive treatment with the Recana Thrombectomy Catheter System, pictured ⁤with Professor​ Gerry O’Sullivan, Consultant Interventional ⁢radiologist at University Hospital Galway, following the successful procedure that represents a global breakthrough in the treatment of complex venous obstructions.

This article was⁤ last modified: July⁣ 31st, ​2025 by Staff ‌Writer.*

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Donegal News, galway university hospital, Kely Coughlin, treatment

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Copyright Notice
  • Disclaimer
  • Terms and Conditions

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service